跳至主要内容
临床试验/TCTR20240612005
TCTR20240612005招募中3 期

An Open-Label Single-Arm Clinical Trial to Evaluate the Safety and Efficacy of Deferasirox in Pediatric Patients with Transfusion-Dependent Rare Inherited Hemolytic Anemia

Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand0 个研究点目标入组 20 人开始时间: 2024年6月12日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Months 至 20 Years(—)
性别
All

入选标准

  • 1. Patients diagnosed with IHA (RBC membranopathy, enzymopathy, or KLF1 insufficiency) aged 18 months to 20 years who have been followed up at Hematology Clinic, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand
  • 2. Transfusion-dependent patients (have been receiving RBC transfusion at the interval of 8 weeks or shorter for at least 6 months)
  • 3. Serum ferritin level 1,000 ng/mL or more measured for 2 consecutive times (at least 1 month apart)

排除标准

  • 1. Patients and/or guardians denied consent
  • 2. Patients have been diagnosed with thalassemia
  • 3. History of deferasirox allergy

研究者

发起方
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand

相似试验